Early steroid therapy for respiratory failure

J. A. Weigelt, J. F. Norcross, K. R. Borman and W. H. Snyder 3rd

We performed a randomized double-blind trial to determine the usefulness of early methylprednisolone therapy for patients with pulmonary failure. We selected 81 acutely ill, mechanically ventilated patients at high risk for adult respiratory distress syndrome (ARDS). Thirty-nine patients received methylprednisolone, 30 mg/kg, every six hours for 48 hours; 42 patients received mannitol placebo. All patients were given a positive end-expiratory pressure of 5 cm H2O, monitored with pulmonary artery catheters, and treated for their primary disease processes. Twenty-five steroid-treated patients (64%) and 14 placebo-treated patients (33%) developed ARDS. Early infectious complications occurred in 30 steroid-treated patients (77%) and 18 placebo-treated patients (43%). There were no significant differences in factors predisposing to ARDS, ventilatory requirements, or days of intensive care. These results do not support the use of methylprednisolone for ARDS. Steroids failed to improve pulmonary function and were associated with an increased infection rate. Intensive pulmonary and general supportive care remain the preferred therapy for ARDS.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Corticosteroids in severe pneumonia
Sibila et al.
Eur Respir J 2008;32:259-264.
ABSTRACT | FULL TEXT  

Nonventilatory Interventions in the Acute Respiratory Distress Syndrome
Schuster et al.
J Intensive Care Med 2008;23:19-32.
ABSTRACT  

Glucocorticoids for ARDS: Just Do It!
Annane
Chest 2007;131:945-946.
FULL TEXT  

Nonventilatory Treatments for Acute Lung Injury and ARDS
Calfee and Matthay
Chest 2007;131:913-920.
ABSTRACT | FULL TEXT  

Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.
Cepkova and Matthay
J Intensive Care Med 2006;21:119-143.
ABSTRACT  

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
The National Heart, Lung, and Blood Institute Acut
NEJM 2006;354:1671-1684.
ABSTRACT | FULL TEXT  

Acute Respiratory Distress Syndrome: A Historical Perspective
Bernard
Am. J. Respir. Crit. Care Med. 2005;172:798-806.
ABSTRACT | FULL TEXT  

Acute Respiratory Distress Syndrome
Burleson and Maki
Journal of Pharmacy Practice 2005;18:118-131.
ABSTRACT  

Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome
Levy et al.
Am. J. Respir. Crit. Care Med. 2005;171:518-526.
ABSTRACT | FULL TEXT  

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane et al.
BMJ 2004;329:480.
ABSTRACT | FULL TEXT  

Pediatric Acute Hypoxemic Respiratory Failure: Management of Oxygenation
Prodhan and Noviski
J Intensive Care Med 2004;19:140-153.
ABSTRACT  

Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS
Meduri et al.
Eur Respir J 2003;22:57s-64s.
ABSTRACT | FULL TEXT  

Steroids for Septic Shock: Back From the Dead? (Pro)
Balk
Chest 2003;123:490S-499S.
ABSTRACT | FULL TEXT  

The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS
Cranshaw et al.
Thorax 2002;57:823-829.
ABSTRACT | FULL TEXT  

The role of steroids following major trauma
Lockey and Manara
Trauma 2001;3:53-61.
ABSTRACT  

Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome
MARSHALL et al.
Am. J. Respir. Crit. Care Med. 2000;162:1783-1788.
ABSTRACT | FULL TEXT  

Corticosteroids in Acute Respiratory Failure
JANTZ and SAHN
Am. J. Respir. Crit. Care Med. 1999;160:1079-1100.
FULL TEXT